Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2011 Nov 10;32(2):516–522. doi: 10.1161/ATVBAHA.111.237040

Figure 3.

Figure 3

Event rates for major adverse cardiac events (MACE) stratified according to tertiles of ceruloplasmin (Cp) and high-sensitivity C-reactive protein (hsCRP, top) and myeloperoxidase (MPO, bottom)